Asset Details
Do you wish to reserve the book?
Inhaled Nitric Oxide Therapy in Adults
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inhaled Nitric Oxide Therapy in Adults
Do you wish to request the book?
Inhaled Nitric Oxide Therapy in Adults
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Inhaled Nitric Oxide Therapy in Adults
2005
Overview
The therapeutic promise of nitric oxide (NO), a potent vasodilator, remains uncertain for adults, and licensed indications are restricted to pediatric practice. This review considers the biologic actions of inhaled nitric oxide, the clinical indications for its administration in adults, and an assessment of its potential therapeutic development.
This review considers the biologic actions of inhaled nitric oxide, the clinical indications for its administration in adults, and an assessment of its potential therapeutic development.
Background and Historical Perspective
Nitric oxide was largely regarded as a toxic pollutant until 1987, when its biologic similarities to endothelium-derived relaxing factor were demonstrated.
1
Subsequently, nitric oxide and endothelium-derived relaxing factor were considered a single entity, modulating vascular tone through the stimulated formation of cyclic guanosine 3',5'-monophosphate (Figure 1).
2
Endogenous nitric oxide is formed from the semiessential amino acid L-arginine by one of three (neural, inducible, and endothelial) isoforms of nitric oxide synthase. The physiologic role of endogenous nitric oxide was first shown when an infusion of an inhibitor of all forms of nitric oxide synthase in healthy volunteers . . .
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Adults
/ Anemia, Sickle Cell - drug therapy
/ Biological and medical sciences
/ Cardiovascular System - drug effects
/ Humans
/ Hypertension, Pulmonary - drug therapy
/ Muscle, Smooth, Vascular - drug effects
/ Muscle, Smooth, Vascular - physiology
/ Nitric Oxide - therapeutic use
/ Respiratory Distress Syndrome, Adult - drug therapy
